Clinical Trial Update: Radiation Therapy With or Without RSR13 in Treating Patients With Brain Metastases [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating radiation therapy with or without RSR13 in patients with brain metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Cancer

Drugs mentioned

• RSR13 (RSR13)

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Metastatic Cancer | Phase 3 | Status: COMPLETED